Trial intelligence / Profile preview

Tom-Ox and Radiotherapy in Locally Advanced Rectal Cancer

NCT02723253Phase 2Completed

Sponsor
Sant'Orsola-Malpighi University Hospital
Start
Jan 2005
Primary completion
Jan 2008
Modality
DNA Intercalators/Alkylators
01

Overview

A Phase 2 trial of raltitrexed, oxaliplatin in rectal cancer, sponsored by Sant'Orsola-Malpighi University Hospital. Started Jan 2005; status: completed.

02

Drugs

raltitrexedoxaliplatin
03

Conditions

rectal cancer

Beyond the preview

Go deeper on NCT02723253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02723253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call